An epigenetic modifier triggers therapeutic immune responses against breast cancer

Lorenzo Galluzzi; Guido Guido Kroemer

doi:10.1080/2162402x.2017.1313376

Related publications

Article2016

Positive impact of autophagy in human breast cancer cells on local immunosurveillance

Sylvain Ladoire, David Enot, Laura Senovilla, Marie Chaix, Laurence Zitvogel, Guido Guido Kroemer

Preprint2023

Tumor sialylation is a barrier against CD8 T cell-mediated anti-tumor responses and anti-PD-1 resistance in breast cancer

Stefan Mereiter, Gustav Jonsson, Tiago Oliveira, Johannes Helm, David Hoffmann, Markus Abeln, Ann-Kristin Jochum, Wolfram Jochum, Max J. Kellner, Marek Feith, Vanessa Tkalec, Karolina Wasilewska, Jie Jiao, Lukas Emsenhuber, Felix Holstein, Anna C. Obenauf, Leonardo Lordello, Jean–Yves Scoazec, Guido Guido Kroemer, Laurence Zitvogel, Omar Hasan Ali, Lukas Flatz, Rita Gerardy‐Schahn, Anja Muenster-Kuehnel, Johannes Stadlmann, Josef Penninger

Preprint2021

Powerful synergistic effects of a STING agonist and an IL-2 superkine in cancer immunotherapy against MHC I-deficient and MHC I+ tumors

Natalie K. Wolf, Cristina Blaj, Lora K. Picton, Gail Snyder, Li Zhang, Christopher J. Nicolai, Chudi Ndubaku, Sarah M. McWhirter, K. Christopher García, David H Raulet

Article2016

The presence of LC3B puncta and HMGB1 expression in malignant cells correlate with the immune infiltrate in breast cancer

Sylvain Ladoire, David Enot, Laura Senovilla, François Ghiringhelli, Vichnou Poirier-Colame, Kariman Chaba, Michaëla Semeraro, Marie Chaix, Frédérique Penault‐Llorca, Laurent Arnould, Marie Laure Poillot, Patrick Arveux, Suzette Delaloge, Fabrice André, Laurence Zitvogel, Guido Guido Kroemer

Article2024

PD-L1 <sup>+</sup> macrophages suppress T cell-mediated anticancer immunity

Peng Liu, Liwei Zhao, Guido Guido Kroemer, Oliver Kepp